IP Library Assignment 049343/0283
Patent Assignment
Reel/Frame 049343/0283

Assignment of Assignor's Interest

Recorded: 2019-06-03 Pages: 10
Assignors
RABUKA, DAVID
Executed: 2019-04-16
MCFARLAND, JESSE M.
Executed: 2019-04-13
DRAKE, PENELOPE M.
Executed: 2019-04-16
BARFIELD, ROBYN M.
Executed: 2019-04-16
Assignee
R.P. SCHERER TECHNOLOGIES, LLC
CATALENT PHARMA SOLUTIONS, 14 SCHOOLHOUSE ROAD, SOMERSET, NEW JERSEY, 08873
Covered Property (1)
Anti-CD22 Antibody-Maytansine Conjugates and Methods of Use Thereof
Application: 15/774,384 →
Publication: US 2020/0246480
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →